
Passage Bio Inc
NASDAQ:PASG

Intrinsic Value
The intrinsic value of one
PASG
stock under the Base Case scenario is
26.45
USD.
Compared to the current market price of 5.9 USD,
Passage Bio Inc
is
Undervalued by 78%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Passage Bio Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Passage Bio Inc
Balance Sheet Decomposition
Passage Bio Inc
Current Assets | 66.7m |
Cash & Short-Term Investments | 63.4m |
Other Current Assets | 3.3m |
Non-Current Assets | 19.3m |
PP&E | 19.1m |
Other Non-Current Assets | 274k |
Free Cash Flow Analysis
Passage Bio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Passage Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-60.9m
USD
|
Operating Income
|
-60.9m
USD
|
Other Expenses
|
-2.5m
USD
|
Net Income
|
-63.5m
USD
|
PASG Profitability Score
Profitability Due Diligence
Passage Bio Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
Passage Bio Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
PASG Solvency Score
Solvency Due Diligence
Passage Bio Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Score
Passage Bio Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PASG Price Targets Summary
Passage Bio Inc
Dividends
Current shareholder yield for PASG is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PASG
stock under the Base Case scenario is
26.45
USD.
Compared to the current market price of 5.9 USD,
Passage Bio Inc
is
Undervalued by 78%.